Rocket


News + Filings
Transactions
Holdings





All
13F
13D/G
Other



Flagship Pioneering Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/15/2023 4 Flagship Ventures Fund V General Partner LLC (10% Owner) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Unknown transaction of 683,760 shares @ $14.92, valued at $10.2M
Unknown transaction of 113,960 shares @ $14.92, valued at $1.7M
08/14/2023 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
07/13/2023 4 Flagship Ventures Fund IV General Partner LLC (10% Owner) has filed a Form 4 on Evelo Biosciences, Inc.
Txns: Bought 1,082,251 shares @ $2.31, valued at $2.5M
Bought 1,082,251 shares @ $2.31, valued at $2.5M
Bought 3,246,753 shares @ $2.31, valued at $7.5M
02/27/2023 4 Flagship Pioneering Inc. (10% Owner) has filed a Form 4 on Omega Therapeutics, Inc.
Txns: Bought 1,993,986 shares @ $5.78, valued at $11.5M
Bought 1,329,324 shares @ $5.78, valued at $7.7M
02/14/2023 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
11/14/2022 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
10/17/2022 3 Flagship Pioneering Inc. (10% Owner) has filed a Form 3 on Axcella Health Inc.
08/15/2022 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
07/07/2022 4 Nutritional Health LTP Fund General Partner LLC (10% Owner) has filed a Form 4 on Seres Therapeutics, Inc.
Txns: Bought 2,912,748 shares @ $3.15, valued at $9.2M
Bought 5,825,495 shares @ $3.15, valued at $18.4M
06/01/2022 4 Flagship Ventures Fund IV General Partner LLC (10% Owner) has filed a Form 4 on Evelo Biosciences, Inc.
Txns: Bought 4,383,561 shares @ $1.46, valued at $6.4M
Bought 1,095,890 shares @ $1.46, valued at $1.6M
Bought 1,369,863 shares @ $1.46, valued at $2M
Bought 6,849,315 shares @ $1.46, valued at $10M
Bought 13,698,630 shares @ $1.46, valued at $20M
05/16/2022 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
02/14/2022 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
11/15/2021 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
08/16/2021 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
08/05/2021 4 Flagship Pioneering Inc. (10% Owner) has filed a Form 4 on Omega Therapeutics, Inc.
Txns: Converted 1,088,470 shares @ $0
Converted 5,896,386 shares @ $0
Converted 8,396,825 shares @ $0
Bought 220,588 shares @ $17, valued at $3.7M
Converted 970,588 shares @ $0
Converted 4,852,943 shares @ $0
Bought 661,764 shares @ $17, valued at $11.2M
Converted 1,323,529 shares @ $0
Bought 294,117 shares @ $17, valued at $5M
Converted 4,112,000 convertible preferred @ $0
Converted 22,275,232 convertible preferred @ $0
08/05/2021 4 Flagship Pioneering Inc. (10% Owner) has filed a Form 4 on Omega Therapeutics, Inc.
Txns: Converted 1,088,470 shares @ $0
Converted 5,896,386 shares @ $0
Converted 8,396,825 shares @ $0
Bought 220,588 shares @ $17, valued at $3.7M
Converted 970,588 shares @ $0
Converted 4,852,943 shares @ $0
Bought 661,764 shares @ $17, valued at $11.2M
Converted 1,323,529 shares @ $0
Bought 294,117 shares @ $17, valued at $5M
Converted 4,112,000 convertible preferred @ $0
Converted 22,275,232 convertible preferred @ $0
07/29/2021 3 Flagship Pioneering Inc. (10% Owner) has filed a Form 3 on Omega Therapeutics, Inc.
07/29/2021 3 Flagship Pioneering Inc. (10% Owner) has filed a Form 3 on Omega Therapeutics, Inc.
05/17/2021 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
02/16/2021 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
02/10/2021 4 Flagship Ventures Fund V General Partner LLC (10% Owner) has filed a Form 4 on Sana Biotechnology, Inc.
Txns: Converted 1,487,371 shares @ $0
Converted 9,725,122 shares @ $0
Converted 11,441,326 shares @ $0
Converted 11,585,199 shares @ $0
Converted 1,487,371 convertible preferred @ $0
Converted 9,725,122 convertible preferred @ $0
Converted 11,441,326 convertible preferred @ $0
Converted 11,585,199 convertible preferred @ $0
02/03/2021 3 Flagship Ventures Fund V General Partner LLC (10% Owner) has filed a Form 3 on Sana Biotechnology, Inc.
12/10/2020 4 Flagship Ventures Fund V General Partner LLC (10% Owner) has filed a Form 4 on Sigilon Therapeutics, Inc.
Txns: Converted 8,888,888 shares @ $0
Converted 1,481,481 shares @ $0
Converted 4,444,444 convertible preferred @ $0
Converted 4,074,074 convertible preferred @ $0
Converted 370,370 convertible preferred @ $0
Converted 1,481,481 convertible preferred @ $0
12/03/2020 3 Flagship Ventures Fund V General Partner LLC (10% Owner) has filed a Form 3 on Sigilon Therapeutics, Inc.
11/25/2020 4 Flagship Ventures Fund IV General Partner LLC (10% Owner) has filed a Form 4 on Seres Therapeutics, Inc.
Txns: Disposed of 3,587,820 shares @ $0
Disposed of 642,180 shares @ $0
Disposed of 966,234 shares @ $0
Disposed of 1,186,310 shares @ $0
Disposed of 1,481,481 shares @ $0
Disposed of 43,154 shares @ $0
11/16/2020 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
10/29/2020 4 Flagship Ventures Fund V General Partner LLC (10% Owner) has filed a Form 4 on Foghorn Therapeutics Inc.
Txns: Converted 4,054,054 shares @ $0
Converted 4,504,504 shares @ $0
Converted 722,320 shares @ $0
Bought 50,000 shares @ $16, valued at $800k
Converted 1,441,441 shares @ $0
Bought 50,000 shares @ $16, valued at $800k
Converted 1,801,801 shares @ $0
Bought 50,000 shares @ $16, valued at $800k
Converted 7,500,000 convertible preferred @ $0
Converted 8,333,333 convertible preferred @ $0
Converted 1,336,293 convertible preferred @ $0
10/22/2020 3 Flagship Ventures Fund V General Partner LLC (10% Owner) has filed a Form 3 on Foghorn Therapeutics Inc.
10/13/2020 3 Flagship Ventures Fund V General Partner LLC (10% Owner) has filed a Form 3 on Codiak BioSciences, Inc.
08/13/2020 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
07/01/2020 3 Nutritional Health LTP Fund General Partner LLC (10% Owner) has filed a Form 3 on Evelo Biosciences, Inc.
05/14/2020 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
02/13/2020 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
11/14/2019 13F-HR Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy